Effect of Gastric Bypass on Patients With Type 2 Diabetes and/or Dyslipidemia

Completed

• Conditions: Type 2 Diabetes

• Registration Number: NCT00879125
• Lead Sponsor: Vanderbilt University

Brief Summary

This is a retrospective review of patients who have undergone bariatric surgery at VUMC and who have type 2 Diabetes and/or dyslipidemia. The investigators have previously found that gastric bypass significantly improves diabetes 6-12 months after surgery. The investigators are interested in looking at the longer term results after surgery.

Detailed Description

Review and record changes in the subject's medication. subjects vitals: weight, blood pressure, and fasting blood values, which include:

* HbA1c

* Fasting blood glucose

* Fasting Insulin

* Lipid Panel ( total cholesterol, LDL, HDL and triglycerides) were obtained.

Study Timeline

• Study Start: 1999-11
• Primary Completion: 2007-11
• Study Completion: 2007-11
• Study First Submitted: 2009-04-08
• Study First Submitted QC: 2009-04-08
• Study First Posted: 2009-04-09
• Status Verified: 2009-09
• Last Update Submitted: 2009-09-10
• Last Update Posted: 2009-09-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 219

Inclusion Criteria

Patients who have had diabetes and/or dyslipidemia prior to gastric by-pass. -

Exclusion Criteria

Patients who have had type 2 diabetes that was diet controlled at time of surgery; and debilitated patients who are unable to come in for a physical exam.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
glycemic control	one year

Secondary Outcome Measures

Name	Time	Method
Correction of lipid profiles	one year

Trial Locations

Locations (1)

Vanderbilt University Medical Center; 🇺🇸 Nashville, Tennessee, United States